Group | Pre-challenge status (mIU/mL) | N | ≥10 mIU/mL | ≥100 mIU/mL | GMC |
---|---|---|---|---|---|
% or Value (95% CI) | |||||
HBV_2D | <3.3 | 6 | 100 (54.1 - 100) | 66.7 (22.3 - 95.7) | 277.5 (24.7 - 3117.3) |
3.3 to <10 | 6 | 100 (54.1 - 100) | 83.3 (35.9 - 99.6) | 821.7 (142.8 - 4729.5) | |
10 to 100 | 26 | 100 (86.8 - 100) | 100 (86.8 - 100) | 6117.3 (2875.1 - 13015.7) | |
≥100 | 15 | 100 (78.2 - 100) | 100 (78.2 - 100) | 49745.4 (24663.9 - 100332.9) | |
HBV_3D | <3.3 | 1 | 100 (2.5 - 100) | 0.0 (0.0 - 97.5) | 37.4 (-) |
3.3 to <10 | 0 | - | - | - | |
10 to 100 | 9 | 100 (66.4 - 100) | 100 (66.4 - 100) | 6048.5 (2414.6 - 15150.9) | |
≥100 | 11 | 100 (71.5 - 100) | 100 (71.5 - 100) | 65723.7 (34920.1 - 123699.6) | |
Pooled | <3.3 | 7 | 100 (59.0 - 100) | 57.1 (18.4 - 90.1) | 208.4 (26.3 - 1648.7) |
3.3 to <10 | 6 | 100 (54.1 - 100) | 83.3 (35.9 - 99.6) | 821.7 (142.8 - 4729.5) | |
10 to 100 | 35 | 100 (90.0 - 100) | 100 (90.0 - 100) | 6099.5 (3396.3 - 10954.1) | |
≥100 | 26 | 100 (86.8 - 100) | 100 (86.8 - 100) | 55967.0 (35483.1 - 88276.2) |